Skip to main content
CYRX logo

CYRX · Cryoport, Inc.

Track CYRX — free
$15.55 +0.28 (+1.83%) At close · Sep 11
Market Cap
$787.59M
Shares
50.65M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$15.55 Open$15.46 Day$15.39–15.80 52W close$7.72–17.13 Avg vol 30d526K Short int2.7M · 5.4% float · 4.9d Short vol64% Last earningsAug 6, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 6, 2026 Est · unconfirmed · in 8 wks
filed Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$186.45M
Trailing 12 months
Net income (TTM)
−$37.39M
Trailing 12 months
Revenue growth YoY
+7.7%
Year over year
Operating margin
-21.2%
Trailing 12 months
P / E (TTM)
Trailing earnings
FCF yield
-2.5%
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
+0.4%
Year over year · more shares
Price change (1Y)
+64.2%
Trailing year
Short interest
5.4%
Latest settlement · 4.9 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Aug 6, 2026
Q2 FY26

TL;DR. Cryoport reported Q2 2026 revenue of $49.0 million, up 8% year-over-year, achieved positive adjusted EBITDA from continuing operations of $0.4 million, and is affirming full-year 2026 revenue guidance of $192 to $196 million despite macroeconomic/geopolitical uncertainties.

Bullish
  • + Net cash from operating activities improved by approximately $17 million in H1 2026 to about $5 million positive
  • + Clinical trial count grew to a record 779 globally (net +51 YoY), with Phase 3 trials up to 94, supporting future commercial conversions
Bearish
  • Total gross margin declined to 46.6% in Q2 2026 from 47.0% in Q2 2025
  • Management chose to affirm rather than raise full-year 2026 revenue guidance, citing geopolitical and macroeconomic uncertainties

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Neutral Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.60
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +30%
above
Price vs 50-day avg −1%
below
RSI (14) 48
neutral
MACD trend Negative
52-week position 83%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +3%
trailing
6-month return +93%
trailing
YTD return +62%
this year
Relative strength +76%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $16 › 200d $12 — 50d above 200d
Institutional flow Accumulating
+11% holders QoQ · +37 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.36% of float · ▲ +7.9% MoM · 4.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
185 holders — near 3-yr high, broad support
Squeeze score 66
elevated · 0–100
Fundamentals
Excellent
Revenue growth +12%
Y/Y
Gross margin 47%
expanding
EPS growth +156%
Y/Y
Free cash flow $-25.0M
Buyback $63.9M
remaining
Quant / Vol
risk profile
Very High
Volatility 53%
annualized · 1-yr
Max drawdown −32%
past year
ATR 4.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jun 30, 2026
Full-year 2026 revenue · full-year 2026 Initiated $192M – $196M
prior FY $176.18M midpoint +10.1% Y/Y
Prior guidance period ended · from the 8-K filed Aug 6, 2024
Annualized cost savings · second half of 2024 $22M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 5 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+30% Bullish
Price vs 50-day avg
−1% Neutral
RSI (14)
48 Neutral
MACD trend
Negative Bearish
52-week position
83% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $16 › 200d $12 — 50d above 200d
Institutional flow Accumulating
+11% holders QoQ · +37 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.36% of float · ▲ +7.9% MoM · 4.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
185 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $8 Now $16 · 83% Range high $17
vs 200-day avg +30% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Integrated Freight & Logistics — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CYRX
Cryoport, Inc.
this stock
$787.59M +62.0% +12.4% 5.4%
UPS
United Parcel Service Inc
$85.32B +1.1% +8.2% 3.0%
FDX
Fedex Corp
$73.81B +8.5% 16.7 2.0%
JBHT
Hunt J B Transport Services Inc
$25.40B +39.2% +9.7% 38.4 2.7%
EXPD
Expeditors International Of Washington Inc
$25.04B +29.3% +13.5% 28.0 3.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
185
% held
94.5%
Net QoQ
+26.6K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
177
View
Short & Settlement
Short Interest Rising
Shares short
2.7M
Days to cover
4.9d
Change
+198.2K sh
View
Short Volume
Short vol %
64%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
964
Value
$14.3K
As of
Aug 11, 2026
View
Off-Exchange
Off-exchange %
36.7%
Week of
Aug 3, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Josh Gottheimer
Amount
$1.0K–$15.0K
Traded
Sep 15, 2023
View
Financials
Financials
Revenue (FY)
$176.2M
Net income (FY)
$78.3M
EPS diluted
$1.40
View
Buybacks
Authorized
$200.0M
Remaining
$63.9M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 6, 2026
This year
8
View
Proposed Sales
Value
$426.8K
Shares
28.8K
Filed
Aug 11, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 6, 2026
View

Performance

5D 20D 120D MTD YTD
CYRX -2.0% +2.8% +93.4% -2.8% +62.0%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -0.8% +4.5% +75.6% -2.5% +49.9%

Capital returns

Buyback program · as of Mar 3, 2026
Authorized
$200.00M
Spent (derived)
$136.10M
Remaining
$63.90M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1124524 CUSIP 229050307 13F (30d) 97 filings 97 filers Visit website Investor relations